EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Novavax price target lowered to $12 from $14 at BofA
BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...
Harborside Apartments completed in Watkins Glen as work begins on Clute Park. What to know
Work is completed at Harborside Village Apartments and now underway on an ADA accessible playground at Clute Park in Watkins ...
Veterans voices of Grand Valley Veterans sharing their story
GRAND JUNCTION, Colo. ( KREX) — Marine Veterans Ed Wacker and Michael Shockley share a glimpse of their stories serving in ...
Stray of the Day: Meet Alfie
SIOUX CITY, Iowa (KCAU) — Meet today’s Stray of the Day: Alfie. Alfie is a one-to-two-year-old male, short-hair, brown tabby ...
AOL1d
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
Novavax's (NVAX) stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for ...
STAT1d
When even an ‘over the wall’ PIPE can’t help
Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...
Business Insider2d
Novavax Resumes Phase 3 Vaccine Trials After FDA Hold
The latest update is out from Novavax ( (NVAX)). Novavax, a leader in vaccine development, announced the FDA’s removal of a clinical hold on their COVID-19-Influenza combination and influenza vaccine ...